A new type of MRI scan could help doctors diagnose prostate cancer more accurately and spare thousands of men harm from unnecessary biopsies, according to UCL research.
The BRC has published the latest edition of its e-Magazine, Research Breakthroughs.
A single gene therapy injection could dramatically reduce the bleeding risk faced by people with haemophilia B, a study at UCL has found.
The BRC is seeking a patient and public involvement manager on behalf of the NIHR Blood and Transplant Research Unit (BTRU).
An innovative clinical trial aiming to improve the treatment of myeloma – currently an incurable blood cancer – has opened at UCLH.
Read the latest edition of the NIHR UCLH Clinical Research Facility’s (CRF) early phase cancer trials newsletter.
Researchers are working with patients and the public to develop a UK action plan for hearing loss and tinnitus research.
UCL has been ranked among the top 10 universities in the world according to the 2023 QS World University Rankings.
UCLH has launched a new service to make it easier for researchers to access data for research.
UCLH is starting a major study looking at barriers to the recruitment of patients from ethnic minority groups into clinical trials.
A smartphone app that identifies severe neonatal jaundice could provide a cheaper alternative to expensive screening procedures, according to a study by UCLH, UCL and the University of Ghana.
The BRC’s Obesity theme lead Professor Rachel Batterham has received an OBE in the Queen’s Jubilee Birthday Honours list.
COVID-19 vaccines are effective for most cancer patients but the level of protection offered by vaccines against infection, hospitalisation and death is lower compared with the general population and also wanes more quickly, according to a study in which UCLH participated.
Almost two-thirds of intensive care staff may have experienced a mental health disorder during the Covid-19 winter surge last year, according to a study at UCLH and UCL.
Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly less time in hospital, concludes a first-of-its kind trial led by UCLH, UCL and the University of Sheffield.